Astraveus is developing the Lakhesys - The Benchtop Cell Factory™, a microfluidics-powered platform that integrates hardware, software, and consumables for cell and gene therapy manufacturing. This solution enhances development throughput by up to 100 times while reducing resource consumption by 10 to 20 times, making cell therapies more accessible to patients.
Funding
$16.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Cell and gene therapies face manufacturing bottlenecks due to complex, resource-intensive, and often manual processes, hindering scalability and increasing costs. Traditional methods struggle to meet the growing demand for personalized medicine, limiting patient access to these potentially life-saving treatments.
Solution
Astraveus is developing Lakhesys - The Benchtop Cell Factory™, an integrated microfluidics-powered platform designed to streamline and automate cell and gene therapy manufacturing. This all-in-one system combines hardware, software, and consumables to facilitate end-to-end processing, from research to commercialization. By leveraging microfluidics, Lakhesys achieves significant improvements in development throughput and resource efficiency, accelerating cell therapy development and reducing overall costs. The platform's closed and automated nature ensures process reproducibility and minimizes the risk of contamination, supporting cGMP compliance.
Target Audience
The primary target audience includes cell and gene therapy developers, researchers, and manufacturers seeking to improve process efficiency, reduce costs, and accelerate the development of novel therapies.
Features
- Integrated hardware, software, and consumables for end-to-end cell therapy processing
- Microfluidics-based technology for precise control and automation of cell manipulation
- Up to 100x increase in development throughput compared to traditional methods
- 10- to 20-fold reduction in resource consumption, lowering manufacturing costs
- cGMP-compatible design for clinical and commercial manufacturing
- Software suite for process monitoring, data analysis, and workflow management